SCYNEXIS develops antifungal drugs for hard to treat fungal infections, aimed at hospital patients and the physicians who treat them. It last closed at $2.38 on Nov 20, down 8.64% on the day. For the quarter ended Sep 2026, SCYX reported EPS of -$0.71 on revenue of $0, with revenue down 100.0% from a year ago. Over its last 6 reports the stock moved an average of 8.0% the session after earnings.
AI Auto Pilots
Is SCYX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SCYX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on SCYXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
SCYX · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 43% below its 20 day and 67% below its 50 day average. It is 125% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 19), oversold. The nearest support is the 52 week low at $2.30, and the nearest resistance the Pivot at $2.47.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 12.1%/day
Key levels
$9.1252 week high+283.2%
$5.35200 day average+124.8%
$4.38100 day average+84.0%
$3.9850 day average+67.2%
$3.98Swing high (Oct 21)+67.2%
$3.4120 day average+43.3%
$2.64Pivot R1+10.9%
$2.47Pivot+3.8%
$2.38Last close
$2.3052 week low−3.4%
$2.21Pivot S1−7.1%
Indicators
RSI (14)
19.40
Oversold below 30
Oversold
MACD
-0.39
Below its signal line
Bearish
Stochastic
6.8
Near the bottom of its range
Oversold
ADX (14)
34.8
Trending down
Williams %R
-95.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-176.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−32.0%
Change over 10 sessions
Bearish
ATR (14)
$0.29
Typical daily range, 12.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 33.7%/day
Key levels
$9.1252 week high+283.2%
$5.35200 day average+124.8%
$4.38100 day average+84.0%
$3.9850 day average+67.2%
$3.98Swing high (Oct 21)+67.2%
$3.4120 day average+43.3%
$2.64Pivot R1+10.9%
$2.47Pivot+3.8%
$2.38Last close
$2.3052 week low−3.4%
$2.21Pivot S1−7.1%
Indicators
RSI (14)
30.32
Weak, oversold below 30
Neutral
MACD
-0.64
Below its signal line
Bearish
Stochastic
4.5
Near the bottom of its range
Oversold
ADX (14)
13.3
No clear trend
Williams %R
-97.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-199.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−50.8%
Change over 10 sessions
Bearish
ATR (14)
$0.80
Typical daily range, 33.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for SCYX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SCYX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow SCYX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for SCYXHow many large options trades hit SCYX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in SCYX in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SCYX is in one of them and how their past SCYX trades turned out.
SCYNEXIS is a pharmaceutical company based in Jersey City, New Jersey, that develops antifungal medicines. Its approved product, BREXAFEMME, treats vaginal yeast infections, and it has been licensed to GSK. Its main development candidate, SCY-247, is an oral and intravenous antifungal being studied for serious fungal infections, mainly in hospital patients with weakened immune systems and in other patients at high risk. The company's customers are mainly physicians at major medical centers who treat these patients.